Single-center experience of robot-assisted radical cystectomy (RARC) and extended pelvic lymph node dissection
dc.contributor.author | Boga, Mehmet Salih | |
dc.contributor.author | Ozsoy, Cagatay | |
dc.contributor.author | Aktas, Yasin | |
dc.contributor.author | Aydin, Arif | |
dc.contributor.author | Savas, Murat | |
dc.contributor.author | Ates, Mutlu | |
dc.date.accessioned | 2024-02-23T14:41:17Z | |
dc.date.available | 2024-02-23T14:41:17Z | |
dc.date.issued | 2020 | |
dc.department | NEÜ | en_US |
dc.description.abstract | Objective: To report the outcomes of robot-assisted radical cystectomy (RARC) and extended pelvic lymph node dissection (ePLND) series for bladder cancer. Material and methods: Between October 2016 and June 2019, overall 57 patients (50 men, 7 women) were included in the study. Patient demographics, operative data, and postoperative pathological outcomes were evaluated. Patients who had a history of pelvic or intraabdominal surgery due to other concurrent malignancy, radiation therapy, or lacked data were excluded from the study. Results: The mean age of the patients was 64.72 +/- 9.09 years. The mean operation time, intraoperative estimated blood loss, and hospitalization time were 418.58 +/- 85.66 minutes, 313.00 +/- 79.16mL, and 13.44 +/- 5.25 days, respectively. The postoperative pathological stages were reported as pT0 (n=8), pTis (n=4), pT1 (n=4), pT2 (n=22), pT3a (n=11), pT3b (n=2), pT4a (n=4), pT4b (n=1), and other (n=1). The mean lymph node (LN) yield was 23.45 +/- 943. Positive LNs were found in 16 (28.1%) patients. Surgical margins were positive in 3 (5.26%) patients. The mean follow-up period was 15.42 +/- 8.31 months. According to the modified Clavien-Dindo system, minor (Clavien 1-2) and major (Clavien 3-5) complications occurred in 18 (31.58%) and 9 (15.78%) patients during the early (0-30 days) period and in 4 (7.02%) and 5 (8.77%) patients in the late (31-90 days) period. Conclusion: RARC and ePLND are complex but safe procedures with acceptable morbidity and excellent surgical and oncologic outcomes in muscle-invasive or high-risk bladder tumors. | en_US |
dc.identifier.doi | 10.5152/tud.2020.19265 | |
dc.identifier.endpage | 296 | en_US |
dc.identifier.issn | 2149-3235 | |
dc.identifier.issn | 2149-3057 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 32301693 | en_US |
dc.identifier.scopus | 2-s2.0-85087905872 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 288 | en_US |
dc.identifier.uri | https://doi.org/10.5152/tud.2020.19265 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/16787 | |
dc.identifier.volume | 46 | en_US |
dc.identifier.wos | WOS:000550781400007 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Aves | en_US |
dc.relation.ispartof | Turkish Journal Of Urology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Bladder Tumors | en_US |
dc.subject | Cystectomy | en_US |
dc.subject | Lymphadenectomy | en_US |
dc.subject | Robotics | en_US |
dc.subject | Urinary Diversion | en_US |
dc.title | Single-center experience of robot-assisted radical cystectomy (RARC) and extended pelvic lymph node dissection | en_US |
dc.type | Article | en_US |